In particular, fluorescent immunostaining of tumor tissues using CD31, a marker of vascular endothelial cells, showed that CD31 positivity per unit area of tumor tissue sections increased significantly after treatment with HIF-PHIs. This evidence concerns the gene PECAM1 and neoplasm.